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Background: Phenylalanine hydroxylase (PAH) is the enzyme that metabolizes phenylalanine, an essential amino
acid required for catecholamine synthesis. Rare mutations in PAH are causal to phenylketonuria (PKU), an autosomal
recessive disease characterized by neuropsychiatric symptoms including intellectual disability. We examined
whether there is an association between common single nucleotide polymorphisms (SNPs) of PAH and memory
performance in the Japanese population.
Methods: Subjects were 599 healthy adults (166 males and 433 females; mean age 43.8 ± 15.5 years). The Wechsler
Memory Scale-Revised (WMS-R) was administered to all participants to assess memory performance. Genotyping was
performed for 6 selected tagging SNPs of PAH (rs1722387, rs3817446, rs1718301, rs2037639, rs10860936 and rs11111419).
Results: Analyses of covariance controlling for sex and education years, indicated a significant association between a
SNP (rs2037639) and age-corrected verbal memory index of WMS-R (nominal p = 0.0013) which remained significant
after correction for multiple testing ( p = 0.0013 < 0.0017 = 0.05/30tests). Individuals with the GG genotype showed a
significantly lower mean verbal memory score, compared with those individuals carrying the AA/AG genotype
(106.0 ± 16.0 vs. 111.7 ± 13.4; p = 0.00099). A haplotype block containing two markers of rs2037639 and rs10860936
was associated with verbal memory index (permutation global p = 0.0091).
Conclusions: Our findings suggest that common genetic variations in PAH are associated with verbal memory in healthy
adults. Unknown functional polymorphisms in PAH or those in other genes nearby might affect memory performance.
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Association studyBackground
Accumulating evidence suggests that genetic factors influ-
ence human complex behavior, including neurocognition
throughout the life span [1,2]. Studies of single genes that
cause monogenic diseases with cognitive impairments will
advance understanding of genetic and molecular mecha-
nisms underlying individual differences in neurocognitive
performance [3]. Phenylketonuria [PKU; McKusick OMIM
261600], an inborn error of phenylalanine metabolism,
causes intellectual disability (i.e., developmental disorder
with general cognitive disabilities), seizures, microcephaly,
motor disorder, skin rashes and other symptoms, including* Correspondence: hkunugi@ncnp.go.jp
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reproduction in any medium, provided the orpsychiatric conditions such as depression [4-6]. About 98%
of PKU is caused by mutations in phenylalanine hydroxy-
lase (PAH) on chromosome 12q. PAH encodes phenylalan-
ine hydroxylase [EC 1.14.16.1] that converts phenylalanine
to tyrosine which is a precursor of the neurotransmitter
dopamine and other catecholamines [5,6]. More than 500
mutations in PAH were registered as responsible for PKU
(http://www.pahdb.mcgill.ca/) [6].
Interestingly, previous studies [7,8] reported that poly-
morphisms in PAH confer susceptibility to schizophre-
nia, a disease characterized by pervasive neurocognitive
deficiencies including distinct memory impairment [9],
as well as with psychiatric symptoms.
Based on these observations, we hypothesized that
common genetic variations in PAH might be associated
with neurocognitive function, memory performance inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the possible association of single nucleotide polymor-
phisms (SNPs) of PAH with memory performance in
healthy adults. To our knowledge, there has been no re-
port that examined such an association.
Methods
Subjects
Subjects were 599 healthy Japanese adults (166 males and
433 females; mean age 43.8, standard deviation [SD]
15.5 years). Mean education years of the participants were
15.2 ± 2.7 years. All subjects were biologically unrelated
and were recruited via advertisements of free local maga-
zines in the western part of Tokyo Metropolitan and our
website announcement. All subjects underwent structured
interview using the Japanese version of the Mini Inter-
national Neuropsychiatric Interview (M.I.N.I.) [10,11] and
additional unstructured interview by a research psychiatrist
to confirm no current or past history of any axis І or II dis-
orders in the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM- IV) criteria [12]. Participants
were excluded if they had a current or past contact to psy-
chiatric services, or had a history of severe head injury,
serious central nervous system or physical disease, regu-
lar use of psychotropics, or substance abuse/dependence.
Assessment of memory performance
The Japanese version of Wechsler Memory Scale-
Revised (WMS-R) [13,14] was administered to all partic-
ipants [15,16]. Raw scores of 5 indices, ie, the verbal, vis-
ual and general memory, attention/concentration, and
delayed recall calculated from 13 subtests of WMS-R
were converted to age-corrected standard scores
according to the test manual [14]. The study was ap-
proved by the ethics committee at the National Center
of Neurology and Psychiatry (NCNP), Japan and was
performed in accordance with the Declaration of
Helsinki. Every subject gave written informed consent
after full explanation of the study aim and protocol.
SNPs-selection and genetic analysis
Preparation of genomic DNA from venous whole blood of
subjects was performed according to standard procedures.
We selected 6 tagging SNPs (rs1722387, rs3817446,
rs1718301, rs2037639, rs10860936 and rs11111419)
throughout PAH, encompassing 2 kilobase (kb) of se-
quence upstream and downstream (between chromosome
12 positions 101,754,235 and 101,837,511), using the ‘Tag-
ger’ application of the program Haploview 4.2 (http://
www.broad.mit.edu/mpg/haploview/) (version 3.0 release
R2) [17]. We used the HapMap genotype data of the Han
Chinese from Beijing (CHB) and the Japanese from Tokyo
(JPT) and an r2 threshold of 0.8 with a minor allele fre-
quency (MAF) threshold of 0.1. Genotyping of the SNPswas performed using the TaqMan allelic discrimination
assay (Applied Biosystems, Foster City, CA, USA) with
10 ng human DNA and 1.5 μl 2× qPCRTM Mastermix
Plus Quick Gold Star (EUROGENTIC, Seraing, Belgium).
Polymerase chain reaction was performed with an initial
cycle at 95°C for 10 minutes followed by 50 cycles of 92°C
for 15 seconds and 60°C for 1 minute in GeneAmp PCR
System 9700 (Applied Biosystems). The allele-specific
fluorescence was discriminated with an ABI PRISM 7900
Sequence Detection Systems (Applied Biosystems). Geno-
type data were determined blind to the WMS-R scores.
Ambiguous genotype data were excluded from the analysis.
The call rate of non-missing genotypes was over 97%.
Statistical analysis
The statistical package for the social sciences (SPSS) version
11.0 (SPSS Japan, Tokyo) was used for the analysis of vari-
ance (ANOVA), analysis of covariance (ANCOVA) and χ2
test. Demographic characteristics between genotype groups
was compared by using ANOVA or χ2 test, as appropriate.
The ANCOVA was performed to test the effect of genotype
on each score of the 5 indices of WMS-R, controlling for
sex and education years. Paired comparisons for verbal
memory scores of each genotype were carried out with the
ANCOVA controlling for sex and education years.
Haploview 4.2 was used to check deviation from the Hardy-
Weinberg equilibrium (HWE) for each SNP, and to calculate
measures of linkage disequilibrium (LD). Haplotype blocks
were constructed using the default block search algorithm
of Gabriel et al. [18]. Haplotypes with frequencies below 1%
were not included in the association analysis. The PLINK
statistical package version 1.07 (http://pngu.mgh.harvard.
edu/~purcell/plink) [19] was used for haplotype analyses
with sex and education years, and empirical p values were
obtained based on 10,000 permutations. For the power cal-
culation, G*power software version 3.1.5 (http://www.psy-
cho.uni-duesseldorf.de/abteilungen/aap/gpower3/) was used
[20]. Statistical tests were two-tailed and p values < 0.05 were
considered significant. Since, as to the association analyses
between 6 SNPs and 5 indices of WMS-R, we conducted 30
comparisons, critical p value for multiple testing was set at
0.0017 (=0.05/30 tests). Continuous variables were described
as mean ± SD.
Results
There were no significant group differences in age or smok-
ing status between the genotype groups (e.g., rs2037639
AA/AG/GG) (Additional file 1: Table S1). With respect to
education years, a nominally significant group difference
between the genotype groups was observed for rs2037639
(Additional file 1: Table S1). Therefore in subsequent ana-
lyses, sex and education years were controlled for. Charac-
teristics of the 6 tag SNPs are shown in Table 1. No
significant deviation from the HWE was found for the
Table 1 Characteristics of selected 6 tag SNPs of PAH
SNP Chromosome location Location within PAH HWE p value Call rate (%) SNP alleles Minor allele MAF
rs1722387 101765200 Intron 8 0.60 98.2 A/G A 0.143
rs3817446 101784949 Intron 4 0.21 99.2 A/G A 0.242
rs1718301 101795323 Intron 4 0.64 97.3 A/G A 0.166
rs2037639 101795480 Intron 3 0.26 98.8 A/G G 0.341
rs10860936 101807082 Intron 3 0.77 98.2 C/T C 0.122
rs11111419 101809173 Intron 3 0.66 98.8 A/T T 0.223
HWE Hardy-Weinberg Equilibrium, MAF minor allele frequency.
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dices of WMS-R and nominal p values obtained by
ANCOVA, in which memory index was a dependent vari-
able, genotypes and sex were independent variables and
education years was a covariate. We found 5 out of 30 tests
(6 SNPs × 5 indices of WMS-R) were nominally significant
without correction for multiple testing. Interestingly, all 5
tests were associations with verbal memory index. Even
after Bonferroni correction for multiple testing, the associ-
ation between rs2037639 and verbal memory index
remained significant (p = 0.0013 <0.0017 = 0.05/30). In
addition, we compared indices of WMS-R in only non-
smokers to avoid the possible confounding effects of smok-
ing. ANCOVA controlling for sex and education years
showed that the association between rs2037639 and age-
corrected verbal memory index of WMS-R was significant
for multiple testing (p = 0.00024 < 0.0017, F = 8.5). There-
fore, we do not think that the association between
rs2037639 and age-corrected indices of WMS-R was attrib-
utable to smoking status. In subsequent analyses, we fo-
cused on the effect of rs2037639 on verbal memory.
Figure 1 shows mean verbal memory scores depending on
genotypes of rs2037639. There was a significant difference
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F = 0.38, p =0.69 F = 0.48, p =0.62 F = 1.
P values of co-dominant model of ANCOVA controlling for education years and sex
(p < 0.05) and significant for Bonferroni correction for 30 tests (p < 0.0017 =0.05/30)groups (F = 6.7, df = 2, p = 0.0013) (AA genotype: 112.0 ±
12.6, n = 264; AG: 111.3 ± 14.2, n = 254; GG: 106.0 ± 16.0,
n = 75). In paired comparisons, subjects with GG genotype
showed a significantly lower mean verbal memory score,
compared with subjects with AG (F = 5.4, df = 1, p = 0.021)
and AA genotype (F = 13.4, df = 1, p = 0.00029). No signifi-
cant difference was observed in mean verbal memory
score between individuals with AA and AG genotype (data
not shown). When the AG and AA genotype groups were
combined, ANCOVA controlling for sex and education
years showed that the GG genotype group was signifi-
cantly lower in mean verbal memory score than
the AA/AG group (106.0 ± 16.0 vs. 111.7 ± 13.4; F = 10.9,
df = 1, p = 0.00099).
Figure 2 represents LD coefficients (D’) and construc-
ted two haplotype blocks, block 1 (rs1722387 and
rs3817446) and block 2 (rs2037639 and rs10860936), for
the 6 SNPs of PAH obtained by the Haploview software.
Haplotype analyses for the constructed two haplotype
blocks (blocks 1 and 2) using the PLINK software re-
vealed that haplotype block 2, which contained two
markers (rs2037639-rs10860936), was significantly asso-
ciated with verbal memory index (permutation global
p = 0.0091, Table 3).of the WMS-R
SNP of PAH gene
718301 rs2037639 rs10860936 rs11111419
A/G G/G A/A A/G G/G C/C C/T T/T A/A A/T T/T
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1, p =0.12 F = 6.7, p =0.0013 F = 5.5, p =0.0042 F = 5.0, p =0.0067
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Figure 1 Mean age-adjusted verbal memory scores of WMS-R
grouped by genotypes of PAH SNP rs2037639. Data are
expressed as mean ± standard error. *p < 0.05, ***p < 0.001:
significant differences by analysis of covariance controlling for sex
and education years.
Table 3 Association of PAH haplotypes on verbal memory






Block 1 C-C 0.753 0.060
0.13(rs1722387- rs3817446) T-T 0.140 0.12
C-T 0.103 0.55
Block 2 A-T 0.658 0.0068
0.0091(rs2037639-rs10860936) G-T 0.220 0.25
G-C 0.122 0.012
a Sex- and education years-adjusted p values for haplotypes of each vs. all others.
b Empirical p values on the basis of 10,000 permutations.
PAH phenylalanine hydroxylase gene, WMS-R Wechsler Memory Scale-Revised.
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We examined whether common genetic variations of PAH
are associated with memory performance in Japanese
healthy adults. To our knowledge, this is the first attempt
to examine such an association. We found a nomi-
nally significant association of verbal memory index of
WMS-R with 5 SNPs (rs1722387, rs3817446, rs2037639,
rs10860936 and rs11111419) of the 6 tag SNPs in PAH.
The association between SNP rs2037639 and verbal mem-
ory remained significant after correction for multiple test-
ing. Haplotype-based analysis revealed that a haplotype
containing two markers (rs2037639-rs10860936) was sig-
nificantly associated with verbal memory index. TheseFigure 2 Haplotype block structure of the PAH gene. Two
haplotype blocks (bolded) were constructed for the 6 SNPs of PAH,
using the Haploview program. Numbers in squares represent the
100 × D‘ values. The blank squares mean D′ = 1.0.results suggest that common functional variants in PAH
impact verbal memory performance in healthy adults. Al-
ternatively, there might be a possibility that functional var-
iants in other genes nearby, which would be in linkage
disequilibrium with rs2037639 or the haplotype, may play
a role. Since there were no PKU patients in our sample,
the obtained result cannot be ascribed to mutations re-
sponsible for PKU. Further, considering the carrier fre-
quency for PKU of about 1/150 that corresponds to the
PKU incidence among Japanese of 1/70000 to 1/ 120000
[21,22], the number of individuals heterozygous for a rare
mutation responsible for PKU is estimated to be less than
5 in our sample. Therefore, it is unlikely that the obtained
results are attributable largely to such rare mutations.
Of note, the SNP rs2037639 was previously reported to
be associated with schizophrenia in a male Bulgarian sam-
ple (nominal p = 0.03) [7]. Since verbal memory perform-
ance is one of the most disturbed neurocognitive functions
in schizophrenia, it is possible that the SNP confer suscep-
tibility to schizophrenia, at least in part, via affecting mem-
ory performance, an endophenotype of the disease.
There is evidence that rare PKU mutations in PAH are
related with impaired working memory in humans
[23,24] and chemically induced (ethylnitrosourea, ENU)
mouse model of PKU (Pahenu2) [25]. However, to our
knowledge, there is no report focusing the relationship
between common polymorphisms of PAH and cognition.
Since there is no direct evidence of functional effects of
the SNPs, the mechanism underlying the relationship is
currently unclear. The SNP (rs2037639) may have some
functional effects such as regulation of transcription of
PAH. Alternatively, the SNP might be in linkage disequi-
librium with an unknown functional polymorphism. The
functional effect could alter phenylalanine level, which
then alters tyrosine level and activation of tyrosine hydrox-
ylase. Finally the PAH genotypes could affect dopamine
level in the brain [26,27], which is related with memory
[28]. In addition, neurotransmitter serotonin was also re-
portedly found to be decreased in PKU [29-31], possibly
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on the activity of tryptophan hydroxylase [27]. Serotonin
also affects dopamine metabolism and serotonin itself is
related with human neurocognition.
Previous genetic studies have shown an association of
neurocognition with genes encoding enzymes regu-
lating catecholamine metabolism, such as catechol-O-
methyltransferase (COMT) and monoamine oxidase
(MAO). Krach et al. reported that the functional COMT
Val158Met polymorphism links neural activation pattern
during episodic memory tasks [32]. In their study, 84
healthy subjects performed a memory encoding and a
retrieval task while they underwent fMRI scanning. Bi-
lateral insula and anterior hippocampus activations were
increased linearly with the number of Met alleles (Val/
Val [low PFC dopamine] < Val/Met <Met/Met [high PFC
dopamine]) during memory encoding. Giakoumaki et al.
found that tolcapone, the COMT inhibitor, enhanced
working memory assessed by the letter–number sequen-
cing tasks in healthy subjects with the Val/Val genotype
[33]. On the other hand, Enge et al. found that the
MAOA variable number of tandem repeats (VNTR)
polymorphism, which is located in its promoter region
and controls the transcriptional activity of the gene, was
associated with working memory-related performance,
indicating that n-back performance measured by reac-
tion time was poorer in individuals with MAO-L (the
short allelic variant and lower enzymatic activity) than in
individuals with MAO-H (the long allelic variant and
higher enzymatic activity) [34]. Since PAH converts
phenylalanine to tyrosine which is a precursor of dopa-
mine and other catecholamines, functional PAH variants
could affect synthesis of catecholamines.
There are limitations in the study. The present sample
size may have been small, which is subject to type II errors.
When we performed a post-hoc power analysis to evaluate
the statistical power for the association analysis between
verbal memory index and the PAH rs2037639 genotypes,
the current sample size had a 80% power (β = 0.2) to detect
mean difference of 3.3, 4.9, and 5.4 between AA vs. AG,
AA vs. GG, and AG vs. GG, respectively, at the α (two-
tailed) = 5% level. Further studies with a larger sample size
might be required to detect smaller differences. The mech-
anism by which polymorphisms of PAH influences mem-
ory performance is currently unclear, i.e., there is no direct
evidence of functional effects of the examined SNPs. Fu-
ture animal and human studies are therefore warranted to
elucidate the mechanism.
Conclusions
We performed an association study between genetic var-
iations of PAH and memory performance assessed with
WMS-R in Japanese healthy adults. We obtained evi-
dence suggesting that genetic variation of PAH (SNPrs2037639 and the haplotype containing two markers,
rs2037639 and rs10860936) are associated with verbal
memory. Considering the carrier frequency for rare mu-
tations responsible for PKU, our data suggest that com-
mon functional polymorphisms in PAH impact verbal
memory. Alternatively, functional polymorphisms in
other genes nearby may play a role in genetic basis for
verbal memory.
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